// App-Quantinova.ai

2659 : Factors Influencing Time from Initial Presentation to Start of Plasma Exchange (PEX) in Patients with Acute Thrombotic Thrombocytopenic Purpura (TTP)

Researchers

Presenter

  • Rory McCulloch

Principal Investigators

  • Tom Bull

  • Phillip LR Nicolson

  • Rebecca J Shaw

  • Zara Sayar

  • Alexander Langridge

  • Michala Pettitt

  • Rita Perry

  • David Tucker

  • Marie Scully

Medical Centers

  • Department of Haematology, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom

  • Rheumatology Research Unit, Cambridge University Hospitals, Cambridge, United Kingdom

  • Centre for Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom

  • Royal Liverpool University Hospital, Liverpool, United Kingdom

  • Paediatrics, Whittington Health NHS Trust, London, United Kingdom

  • Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom

  • Birmingham Centre for Observational and Prospective Studies, Birmingham Surgical Trials Consortium, Birmingham, United Kingdom

  • Institute of Applied Health Research, Birmingham Centre for Observational and Prospective Studies, Birmingham, United Kingdom

  • Department of Oncology, Royal Cornwall Hospitals NHS Trust, Truro, United Kingdom

  • Department of Medical Oncology, University College London Hospital, London, United Kingdom

  • Haematology Specialty Trainees in Audit and Research (HaemSTAR) Network, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Genetic Disorder

Disease

  • Thrombotic thrombocytopenic purpura

Biomarkers

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved